1Rege S,Maass A,Chaiken L,et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers [J]. Cancer, 1994,73(12) : 3047.
2Wong WL,Chevretton EB,McGurk M,et al. A prospective study of PET-FDG of head a imaging for the assessment and neck squamous cell carcinoma[J]. Clin Otolaryngol, 1997,22(3) : 209.
3Schipper J,Schrader M,Arweiler D,et al. Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor[J]. HNO, 1996,44(5) :254.
4Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas[J].J Nucl Med, 1995,36(10) : 1747.
5Myers LL,Wax MK ,Nabi H,et al. Repressive coping and the directed forgetting of emotional material[J]. J Abnorm Psychol,1998,107(1) : 141.
6Flanagan FL,Dehdashti F,Siegel BA. PET in breast cancer[J].Semin Nucl Med, 1998,28(4) :290.
7Conti PS, Lilien DL, Hawley K, et al. PET and [ 18F ]-FDG in oncology:a clinical update[J]. Nucl Med Biol, 1996,23(6) :717.
8Wahl RL. Overview of the current status of PET in breast cancer imaging [J]. Q J Nucl Med, 1998,42(1) : 1.
9Lowe VJ, Fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules[J]. J Clin Oncol, 1998,16(3) : 1075.
10Bury T, Dowlati A, Paulus P, et al. Eur Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer [J]. Eur Respir J, 1997,10(11) : 2529.
